Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants()

Recombinant modified vaccinia virus Ankara expressing HIV-1 antigens (MVA.HIVA) was used in ELISpot assays to monitor HIV-1-specific T cell responses in infants. Responses to MVA.HIVA and HIV-1 peptides were examined in 13 infected and 81 exposed uninfected infants in Nairobi, Kenya. Responses to MV...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Slyker, Jennifer A., Lohman, Barbara L., Mbori-Ngacha, Dorothy A., Reilly, Marie, Wee, Edmund G.-T., Dong, Tao, McMichael, Andrew J., Rowland-Jones, Sarah L., Hanke, Tomas, John-Stewart, Grace
Format: Artigo
Langue:Inglês
Publié: 2005
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3382083/
https://ncbi.nlm.nih.gov/pubmed/16043269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2005.01.145
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires